Clinical Research Program
The Wake Forest Baptist Comprehensive Cancer Center (WFBCCC) offers more cancer-related clinical trials than any other hospital in western North Carolina.
Patients with virtually any type of cancer have the opportunity to participate in one of nearly 250 research studies conducted by oncologists from the Comprehensive Cancer Center or by one of the other leading cancer researchers around the country with whom we collaborate.
Most of the studies combine conventional treatments such as surgery, radiation therapy and chemotherapy, with novel molecular therapeutic approaches.
Our Cancer Center also utilizes integrative approaches with complementary and alternative medicines, including vitamin and nutritional therapies, in both cancer treatment and symptom management research. We firmly believe that “research cures cancer” and so do the 1,000 or more of our patients per year who enroll in one or more of our innovative clinical trials. These trials originate from the Cancer Center or one of the national Cooperative Groups of which we are a member:
In addition, WFBCCC is a National Cancer Institute (NCI) funded Community Oncology Research Program (NCORP) Research Base, the only NCI-designated Comprehensive Cancer Center Research Base. As such, it provides a conduit for community
physicians to participate in NCI-supported trials, giving their patients enhanced
access to high-quality research studies in their own communities.Currently, about 30 community sites located across the United States participate in cancer treatment and symptom management studies. These studies address important issues such as treatment-related fatigue, weight loss, hot flashes, depression, cognitive function and nutrition in cancers of the brain, breast, cervix, head and neck, lung, ovary and prostate, as well as soft tissue sarcomas and metastatic disease.
The major goal of the
Clinical Research Program (CRP) of the WFBCCC is to serve as a hypothesis-driven incubator and catalyst for the
clinical translation of novel therapeutic, diagnostic, and supportive care
strategies. This goal is achieved 1)
Translating advances in the understanding of cancer from the WFBCCC’s basic
sciences and population science Programs into novel therapeutic strategies with
correlative biomarkers of response; 2) Promoting the development and conduct of innovative clinical trials for rare or difficult
to treat cancers and sites of metastasis; and 3) Enhancing understanding in cancer-related symptom science, including leveraging the Wake
Forest National Cancer Institute Community Oncology Program Research Base. CRP research is comprised of two themes
within these aims: experimental
therapeutics and addressing health disparities, with particular focus on
cancers of high incidence in the WFBCCC catchment area.
William Blackstock, MD, Program Leader
Glenn Lesser, MD, Program Co-Leader